| Prostate cancer: multiparametric MR imaging for detection, localization, and staging CMA Hoeks, JO Barentsz, T Hambrock, D Yakar, DM Somford, ... Radiology 261 (1), 46-66, 2011 | 769 | 2011 |
| Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer T Hambrock, DM Somford, HJ Huisman, IM van Oort, JA Witjes, ... Radiology 259 (2), 453-461, 2011 | 663 | 2011 |
| Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen T Hambrock, DM Somford, C Hoeks, SAW Bouwense, H Huisman, ... The Journal of urology 183 (2), 520-528, 2010 | 451 | 2010 |
| Comparing three different techniques for magnetic resonance imaging-targeted prostate biopsies: a systematic review of in-bore versus magnetic resonance imaging-transrectal … O Wegelin, HHE van Melick, L Hooft, JLHR Bosch, HB Reitsma, ... European urology 71 (4), 517-531, 2017 | 419 | 2017 |
| The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer DM Somford, EH Hamoen, JJ Fütterer, JP Van Basten, ... The Journal of urology 190 (5), 1728-1734, 2013 | 198 | 2013 |
| The future trial: A multicenter randomised controlled trial on target biopsy techniques based on magnetic resonance imaging in the diagnosis of prostate cancer in patients with … O Wegelin, L Exterkate, M van der Leest, JA Kummer, W Vreuls, ... European urology 75 (4), 582-590, 2019 | 183 | 2019 |
| Diffusion and perfusion MR imaging of the prostate DM Somford, JJ Fütterer, T Hambrock, JO Barentsz Magnetic resonance imaging clinics of North America 16 (4), 685-695, 2008 | 125 | 2008 |
| Influence of arterial input function on hypoperfusion volumes measured with perfusion-weighted imaging VN Thijs, DM Somford, R Bammer, W Robberecht, ME Moseley, ... Stroke 35 (1), 94-98, 2004 | 106 | 2004 |
| Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance–guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer … CMA Hoeks, DM Somford, IM van Oort, H Vergunst, JR Oddens, GA Smits, ... Investigative radiology 49 (3), 165-172, 2014 | 100 | 2014 |
| Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score≤ 3+ 3= 6 upon schematic TRUS-guided … DM Somford, T Hambrock, CA Hulsbergen-van de Kaa, JJ Fütterer, ... Investigative radiology 47 (3), 153-158, 2012 | 96 | 2012 |
| Pharmacokinetic aspects of the two novel oral drugs used for metastatic castration-resistant prostate cancer: abiraterone acetate and enzalutamide GE Benoist, RJ Hendriks, PFA Mulders, WR Gerritsen, DM Somford, ... Clinical pharmacokinetics 55 (11), 1369-1380, 2016 | 82 | 2016 |
| Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer DM Somford, CM Hoeks, CA Hulsbergen-van de Kaa, T Hambrock, ... Investigative radiology 48 (3), 152-157, 2013 | 72 | 2013 |
| Proximal and distal hyperattenuating middle cerebral artery signs at CT: different prognostic implications DM Somford, PJ Nederkoorn, DR Rutgers, LJ Kappelle, WPTM Mali, ... Radiology 223 (3), 667-671, 2002 | 72 | 2002 |
| Drug–drug interaction potential in men treated with enzalutamide: Mind the gap GE Benoist, IM van Oort, S Smeenk, A Javad, DM Somford, DM Burger, ... British journal of clinical pharmacology 84 (1), 122-129, 2018 | 46 | 2018 |
| Complications and Adverse Events of Three Magnetic Resonance Imaging–based Target Biopsy Techniques in the Diagnosis of Prostate Cancer Among Men with Prior Negative Biopsies … O Wegelin, L Exterkate, M van der Leest, JC Kelder, JLHR Bosch, ... European urology oncology 2 (6), 617-624, 2019 | 44 | 2019 |
| Incidence and risk factors of postoperative urinary retention and bladder catheterization in patients undergoing fast-track total joint arthroplasty: a prospective … R Scholten, K Kremers, SAW van de Groes, DM Somford, S Koëter The Journal of arthroplasty 33 (5), 1546-1551, 2018 | 42 | 2018 |
| Lutetium-177-PSMA-617 in Low-Volume Hormone-Sensitive Metastatic Prostate Cancer: A Prospective Pilot Study177Lu-PSMA in Low-Volume Hormone-Sensitive Prostate Cancer BM Privé, S Peters, CHJ Muselaers, IM van Oort, MJR Janssen, ... Clinical Cancer Research 27 (13), 3595-3601, 2021 | 36 | 2021 |
| Oligometastatic prostate cancer: results of a Dutch multidisciplinary consensus meeting SS Aluwini, N Mehra, MP Lolkema, DE Oprea-Lager, D Yakar, ... European urology oncology 3 (2), 231-238, 2020 | 32 | 2020 |
| Is there still a need for repeated systematic biopsies in patients with previous negative biopsies in the era of magnetic resonance imaging-targeted biopsies of the prostate? L Exterkate, O Wegelin, JO Barentsz, MG van der Leest, JA Kummer, ... European urology oncology 3 (2), 216-223, 2020 | 32 | 2020 |
| Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging–guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr … EHJ Hamoen, CMA Hoeks, DM Somford, IM van Oort, H Vergunst, ... European urology focus 5 (3), 407-415, 2019 | 31 | 2019 |
Jelle BarentszProfessor of Radiology, Chairman Radboud Prostate MRI Expert CenterVerified email at radboudumc.nl
